These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 4033807)
1. The lead structure in cardiac glycosides is 5 beta, 14 beta-androstane-3 beta 14-diol. Schönfeld W; Weiland J; Lindig C; Masnyk M; Kabat MM; Kurek A; Wicha J; Repke KR Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):414-26. PubMed ID: 4033807 [TBL] [Abstract][Full Text] [Related]
2. Origin of differences of inhibitory potency of cardiac glycosides in Na+/K+-transporting ATPase from human cardiac muscle, human brain cortex and guinea-pig cardiac muscle. Schönfeld W; Schönfeld R; Menke KH; Weiland J; Repke KR Biochem Pharmacol; 1986 Oct; 35(19):3221-31. PubMed ID: 3021166 [TBL] [Abstract][Full Text] [Related]
3. 5 Beta,14 beta-androstane-3 beta,14-diol binds to the digitalis receptor site on Na/K-ATPase. Schönfeld W; Menke KH; Schönfeld R; Repke KR J Enzyme Inhib; 1987; 2(1):37-45. PubMed ID: 2854155 [TBL] [Abstract][Full Text] [Related]
4. Differentiation between isoforms of Na+/K+-transporting atpase from human and guinea-pig muscle through use of digitalis derivatives as analytical probes. Schön R; Weiland J; Megges R; Repke KR Naunyn Schmiedebergs Arch Pharmacol; 1995 Mar; 351(3):282-92. PubMed ID: 7609782 [TBL] [Abstract][Full Text] [Related]
5. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition. Paula S; Tabet MR; Ball WJ Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774 [TBL] [Abstract][Full Text] [Related]
6. 17beta-O-Aminoalkyloximes of 5beta-androstane-3beta,14beta-diol with digitalis-like activity: synthesis, cardiotonic activity, structure-activity relationships, and molecular modeling of the Na(+),K(+)-ATPase receptor. Cerri A; Almirante N; Barassi P; Benicchio A; Fedrizzi G; Ferrari P; Micheletti R; Quadri L; Ragg E; Rossi R; Santagostino M; Schiavone A; Serra F; Zappavigna MP; Melloni P J Med Chem; 2000 Jun; 43(12):2332-49. PubMed ID: 10882359 [TBL] [Abstract][Full Text] [Related]
7. 17 alpha-O-(aminoalkyl)oxime derivatives of 3 beta,14 beta-dihydroxy-5 beta-androstane and 3 beta-hydroxy-14-oxoseco-D-5 beta-androstane as inhibitors of Na(+),K(+)-ATPase at the digitalis receptor. Gobbini M; Barassi P; Cerri A; De Munari S; Fedrizzi G; Santagostino M; Schiavone A; Torri M; Melloni P J Med Chem; 2001 Nov; 44(23):3821-30. PubMed ID: 11689068 [TBL] [Abstract][Full Text] [Related]
8. Human cell mutants affected in the interaction of the 12 beta-OH group of cardiac glycosides with the digitalis receptor. Gupta RS; Chopra A Biochem Pharmacol; 1987 Nov; 36(22):3829-33. PubMed ID: 2825704 [TBL] [Abstract][Full Text] [Related]
9. The thermodynamic essence of the reversible inactivation of Na+/K+-transporting ATPase by various digitalis derivatives is relaxation of enzyme conformational energy. Beer J; Kunze R; Herrmann I; Portius HJ; Mirsalichova NM; Abubakirov NK; Repke KR Biochim Biophys Acta; 1988 Jan; 937(2):335-46. PubMed ID: 2827773 [TBL] [Abstract][Full Text] [Related]
10. Molecular modelling studies on the digitalis binding site of the Na+/K(+)-ATPase. Höltje HD; Anzali S Pharmazie; 1992 Sep; 47(9):691-7. PubMed ID: 1335579 [TBL] [Abstract][Full Text] [Related]
11. Progesterone derivatives that bind to the digitalis receptor: effects on Na+,K+-ATPase and isolated tissues. LaBella FS; Bihler I; Templeton J; Kim RS; Hnatowich M; Rohrer D Fed Proc; 1985 Sep; 44(12):2806-11. PubMed ID: 2411607 [TBL] [Abstract][Full Text] [Related]
12. Interaction of progesterone derivatives with the digitalis target enzyme: impact of glycosidation on inhibitory potency. Weiland J; Schönfeld W; Menke KH; Repke KR Pharmacol Res; 1991 Jan; 23(1):27-32. PubMed ID: 1710800 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, cardiotonic activity, and structure-activity relationships of 17 beta-guanylhydrazone derivatives of 5 beta-androstane-3 beta, 14 beta-diol acting on the Na+,K(+)-ATPase receptor. Cerri A; Serra F; Ferrari P; Folpini E; Padoani G; Melloni P J Med Chem; 1997 Oct; 40(21):3484-8. PubMed ID: 9341924 [TBL] [Abstract][Full Text] [Related]
14. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase. Brown L; Erdmann E; Thomas R Biochem Pharmacol; 1983 Sep; 32(18):2767-74. PubMed ID: 6313008 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and quantitative structure-activity relationship of 17 beta-(hydrazonomethyl)-5 beta-androstane-3 beta,14 beta-diol derivatives that bind to Na+,K(+)-ATPase receptor. Quadri L; Cerri A; Ferrari P; Folpini E; Mabilia M; Melloni P J Med Chem; 1996 Aug; 39(17):3385-93. PubMed ID: 8765522 [TBL] [Abstract][Full Text] [Related]
16. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation. Cornelius F; Mahmmoud YA Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of progesterone derivatives that bind to the digitalis receptor: modifications in A and B rings. Templeton JF; Kumar VP; Kim RS; LaBella FS Steroids; 1987; 49(4-5):383-96. PubMed ID: 3455050 [TBL] [Abstract][Full Text] [Related]
19. Cardiac glycosides with non-rotating steroid to sugar linkages: tools for the study of digitalis structure-activity relationships. Brown L; Thomas R; Watson T Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):98-102. PubMed ID: 3951571 [TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor. Balzan S; D'Urso G; Ghione S; Martinelli A; Montali U Life Sci; 2000 Sep; 67(16):1921-8. PubMed ID: 11072868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]